Q2 EPS Forecast for Ardent Health Partners Cut by Analyst

Ardent Health Partners, LLC (NYSE:ARDT - Free Report) - Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for shares of Ardent Health Partners in a report issued on Wednesday, May 7th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.59 for the quarter, down from their previous estimate of $0.61. The consensus estimate for Ardent Health Partners' current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners' Q1 2026 earnings at $0.44 EPS, Q3 2026 earnings at $0.52 EPS and FY2028 earnings at $2.88 EPS.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.08. The business had revenue of $1.50 billion for the quarter, compared to analysts' expectations of $1.50 billion.

ARDT has been the subject of several other reports. Stephens reaffirmed an "overweight" rating and set a $22.00 target price on shares of Ardent Health Partners in a research report on Tuesday, April 1st. Morgan Stanley decreased their target price on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research report on Tuesday, January 21st. Royal Bank of Canada reaffirmed an "outperform" rating and set a $21.00 target price on shares of Ardent Health Partners in a research report on Thursday. Mizuho decreased their price objective on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. Finally, Guggenheim lifted their price objective on Ardent Health Partners from $16.00 to $18.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Buy" and a consensus price target of $20.75.

Ardent Health Partners Stock Performance

Shares of Ardent Health Partners stock traded down $0.06 during trading hours on Monday, hitting $15.18. 92,475 shares of the company's stock traded hands, compared to its average volume of 395,868. Ardent Health Partners has a 12-month low of $11.31 and a 12-month high of $20.72. The stock has a market capitalization of $2.17 billion and a price-to-earnings ratio of 9.32. The company has a fifty day simple moving average of $13.10 and a 200-day simple moving average of $14.88. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in ARDT. Ventas Inc. purchased a new position in Ardent Health Partners during the 4th quarter valued at about $159,570,000. Vanguard Group Inc. grew its holdings in shares of Ardent Health Partners by 368.9% during the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company's stock worth $18,296,000 after purchasing an additional 1,046,845 shares in the last quarter. Franklin Resources Inc. purchased a new position in shares of Ardent Health Partners during the third quarter worth about $15,839,000. Nuveen LLC purchased a new position in shares of Ardent Health Partners during the first quarter worth about $6,010,000. Finally, Segall Bryant & Hamill LLC purchased a new position in shares of Ardent Health Partners during the fourth quarter worth about $4,478,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.